Geode Capital Management, LLC Brainstorm Cell Therapeutics Inc. Transaction History
Geode Capital Management, LLC
- $1.07 Trillion
- Q1 2024
A detailed history of Geode Capital Management, LLC transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 357,041 shares of BCLI stock, worth $139,245. This represents 0.0% of its overall portfolio holdings.
Number of Shares
357,041
Previous 357,041
-0.0%
Holding current value
$139,245
Previous $96,000
107.29%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding BCLI
# of Institutions
52Shares Held
4.09MCall Options Held
63.2KPut Options Held
800-
Vanguard Group Inc Valley Forge, PA1.4MShares$546,3870.0% of portfolio
-
Black Rock Inc. New York, NY489KShares$190,8320.0% of portfolio
-
Liberty Wealth Management LLC Oakland, CA340KShares$132,6580.04% of portfolio
-
Weaver Consulting Group199KShares$77,7480.04% of portfolio
-
Caldwell Sutter Capital, Inc. Sausalito, CA157KShares$61,2330.0% of portfolio
About BRAINSTORM CELL THERAPEUTICS INC.
- Ticker BCLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,486,200
- Market Cap $14.2M
- Description
- Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...